Senores Pharmaceuticals cash flow

Latest FY26

Cash from operations: ₹62.1cr−₹45.9 cr in FY25
Capital spending: ₹240cr+52.4% on FY25
Free cash flow: −₹178cr−₹203 cr in FY25
Cash from financing: −₹1.3cr₹573 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025

Adjustments to reconcile profit — non-cash items
	—	31.3	16.8
	—	24.1	0.0
	—	−14.0	0.0
	—	15.2	0.0
	—	1.5	−2.9
Changes in working capital
	—	−30.3	−19.3
	—	−197	−11.9
	—	−56.2	−34.8
	—	−4.3	−4.0
	—	−23.6	−22.4
	—	3.4	0.0
	—	161	−45.8
	—	−4.7	2.7
	—	7.1	1.0
	—	3.5	0.0
Cash from operating activities
	179	159	70.6
	—	−83.9	−121
	—	75.3	−50.0
	—	0.0	−7.2
	—	0.0	−20.4
	—	13.2	9.2
	—	62.1	−45.9
Cash from investing activities
	—	240	158
	—	0.2	0.0
	—	24.6	0.0
	—	4.3	0.0
	—	31.9	3.7
	—	0.0	0.3
	—	0.0	276
	—	14.0	7.2
	—	166	0.0
	—	−121	−429
Cash from financing activities
	—	0.0	472
	—	21.7	0.0
	—	12.7	121
	—	15.7	0.0
	—	1.0	−0.7
	—	24.1	20.4
	—	5.0	0.0
	—	−1.3	573
	—	−59.8	97.7
	—	−59.8	97.7
Reference items
	213	168	89.7
	29.5%	26.6%	22.5%
	−178	−178	−203
	—	−180	—
	−₹38.67	−₹38.67	−₹44.18
	—	0.51×	−0.79×
	—	13.2	9.2
	—	24.1	20.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SENORES₹1,324.30

Senores Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersSANOFI INNOVACAP MOREPENLAB IOLCP FDC PGHL SANOFICONR ORCHPHARMAMcap ₹6,098 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	16.8	31.3	—
+ Finance Costs	0.0	24.1	—
+ Interest Income	0.0	-14.0	—
+ Unrealised FX (Gain) / Loss	0.0	15.2	—
+ Other Non-cash Items	-2.9	1.5	—
Changes in Working Capital
+ Inventories	-19.3	-30.3	—
+ Trade Receivables — Current	-11.9	-197.3	—
+ Other Financial Assets — Current	-34.8	-56.2	—
+ Other Financial Assets — Non-current	-4.0	-4.3	—
+ Other Current Assets	-22.4	-23.6	—
+ Other Non-current Assets	0.0	3.4	—
+ Trade Payables — Current	-45.8	160.5	—
+ Other Financial Liabilities — Current	2.7	-4.7	—
+ Other Current Liabilities	1.0	7.1	—
+ Provisions — Current	0.0	3.5	—
Cash from Operating Activities
Profit Before Tax (per I/S)	70.6	159.1	179.0
+ Total Adjustments (incl. Working Capital)	-120.5	-83.9	—
Cash from Operations (pre-tax)	-50.0	75.3	—
+ Interest Received — Operating	-7.2	0.0	—
+ Interest Paid — Operating	-20.4	0.0	—
+ Income Taxes Paid	9.2	13.2	—
Cash from Operating Activities	-45.9	62.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	157.5	240.1	—
+ Disp of Fixed Assets	0.0	0.2	—
+ Acq of Investment Property	0.0	24.6	—
+ Acq of Other Long-term Assets	0.0	4.3	—
+ Acq of Subsidiaries / Businesses (net)	3.7	31.9	—
+ Loans & Advances Repaid	0.3	0.0	—
+ Payments on Futures / Forwards / Options / Swaps	275.8	0.0	—
+ Interest Received — Investing	7.2	14.0	—
+ Other Inflows / (Outflows) — Investing	0.0	166.1	—
Cash from Investing Activities	-429.5	-120.6	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	471.8	0.0	—
+ Proceeds from Other Equity Instruments	0.0	21.7	—
+ Proceeds from Borrowings	121.0	12.7	—
+ Repayment of Borrowings	0.0	15.7	—
+ Payment of Lease Liabilities	-0.7	1.0	—
+ Interest Paid	20.4	24.1	—
+ Other Inflows / (Outflows) — Financing	0.0	5.0	—
Cash from Financing Activities	573.1	-1.3	—
Net Changes in Cash (pre-FX)	97.7	-59.8	—
Net Changes in Cash	97.7	-59.8	—
Reference Items
EBITDA	89.7	168.3	212.9
EBITDA Margin %	22.52	26.61	29.48
Free Cash Flow (CFO − Capex)	-203.4	-178.1	-178.1
Free Cash Flow to Equity	—	-179.8	—
Free Cash Flow per Basic Share	-44.18	-38.67	-38.67
Cash Flow to Net Income	-0.79	0.51	—
Cash Paid for Taxes	9.2	13.2	—
Cash Paid for Interest	20.4	24.1	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.